- Blind listing
- A listing that never shows the practice name, address, or photos. Identifying details are shared only with buyers the seller approves.
- Asking price
- The price a seller is seeking for the practice. It is a starting point for conversation, not an appraisal.
- Cash flow / EBITDA
- The money the practice earns after operating expenses. EBITDA (earnings before interest, taxes, depreciation, and amortization) is the standard measure buyers use to compare practices.
- Cash-pay mix
- The percentage of revenue that comes from patients paying directly rather than through insurance. Higher cash-pay mix is often valued more predictably.
- REMS
- The FDA's Risk Evaluation and Mitigation Strategy. Spravato can only be dispensed at certified sites, so certification is an asset worth verifying.
- Buy box
- A buyer's saved acquisition criteria — modalities, states, price range, and deal size. Listings that match are flagged automatically.
- Access request
- A buyer's formal request to see more than the blind listing. The seller approves or declines each one individually.
- NDA
- A non-disclosure agreement. On Limneo, buyers sign one after a seller approves their access request and before any detail is shared.
- Data room
- A private, audited folder of practice documents — financials, compliance, payer contracts — visible only to approved buyers with a signed NDA.
- Transition period
- The length of time a selling clinician stays on after closing to introduce buyers, reassure patients, and keep care continuous.